Percentage of Americans with unhealthy triglyceride levels declining
the ONA take:
According to new findings published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS) in NCHS Data Brief, researchers have found that Amercians' triglyceride levels have dropped significantly in the last decade.
Specifically, results showed that the percentage of adults with unhealthy triglyceride levels declined from 33% in 2001-2004 to 25% in 2009-2012.
Triglyceride levels of or higher than 150mg/dL are considered to be unhealthy. For people 60 years of age and older, men with elevated triglyceride levels dropped from 40% in 2001-2004 to 25% in 2009-2012, while women with those levels dropped from 43.5% to 31%.
The study also showed that triglyceride levels declined in overweight and obese people.
The study did not look at causes for the decline in the percentage of people with unhealthy triglyceride levels, but the drops could be from an increase in the number of people taking statin medications and a decline in the number of people smoking.
Amercians' triglyceride levels have dropped significantly in the last decade.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|